OBJECTIVE: The current study examined the performance of a healthy ageing population on the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological test battery in order to determine norms for use in an Australian setting. The effects of age, education, gender and mood on cognitive performance in healthy older individuals were also explored. METHOD: The CERAD neuropsychological battery was administered to a sample of healthy elderly subjects (n = 243). Subjects also completed an anxiety inventory and a depression scale. Means and standard deviations of different age, gender and education groups are reported as normative data. A Principal Components Analysis (PCA) was also calculated. Linear regression was applied to the five factors extracted from the PCA using age, education, gender and mood as independent variables. RESULTS: All recorded means were within 1 SD of those reported in the original CERAD normative study. Five factors that loaded on measures of memory and learning, language, praxis and executive function were extracted. The independent variables age, education and gender all had significant effects on cognitive performance. However, mood had no such effect. CONCLUSIONS: Risk factors for cognitive decline indicated by the CERAD battery include age, education and gender. Anxiety and depression are not associated with CERAD cognitive performance. The CERAD battery is a valid and reliable neuropsychological tool that may assist in the detection and diagnosis of Alzheimer's disease in Australian populations.
OBJECTIVE: The current study examined the performance of a healthy ageing population on the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological test battery in order to determine norms for use in an Australian setting. The effects of age, education, gender and mood on cognitive performance in healthy older individuals were also explored. METHOD: The CERAD neuropsychological battery was administered to a sample of healthy elderly subjects (n = 243). Subjects also completed an anxiety inventory and a depression scale. Means and standard deviations of different age, gender and education groups are reported as normative data. A Principal Components Analysis (PCA) was also calculated. Linear regression was applied to the five factors extracted from the PCA using age, education, gender and mood as independent variables. RESULTS: All recorded means were within 1 SD of those reported in the original CERAD normative study. Five factors that loaded on measures of memory and learning, language, praxis and executive function were extracted. The independent variables age, education and gender all had significant effects on cognitive performance. However, mood had no such effect. CONCLUSIONS: Risk factors for cognitive decline indicated by the CERAD battery include age, education and gender. Anxiety and depression are not associated with CERAD cognitive performance. The CERAD battery is a valid and reliable neuropsychological tool that may assist in the detection and diagnosis of Alzheimer's disease in Australian populations.
Authors: Pauline M Maki; Lorraine Dennerstein; Margaret Clark; Janet Guthrie; Pamela LaMontagne; Deanne Fornelli; Deborah Little; Victor W Henderson; Susan M Resnick Journal: Brain Res Date: 2010-11-13 Impact factor: 3.252
Authors: José R Carrión-Baralt; Josefina Meléndez-Cabrero; Michal Schnaider Beeri; Mary Sano; Jeremy M Silverman Journal: Dement Geriatr Cogn Disord Date: 2009-03-17 Impact factor: 2.959
Authors: Kathleen M Hayden; Richard N Jones; Catherine Zimmer; Brenda L Plassman; Jeffrey N Browndyke; Carl Pieper; Lauren H Warren; Kathleen A Welsh-Bohmer Journal: Alzheimer Dis Assoc Disord Date: 2011 Apr-Jun Impact factor: 2.703
Authors: Lisa D Hankee; Sarah R Preis; Ryan J Piers; Alexa S Beiser; Sherral A Devine; Yulin Liu; Sudha Seshadri; Philip A Wolf; Rhoda Au Journal: Exp Aging Res Date: 2016 Jul-Sep Impact factor: 1.645
Authors: Mary Ganguli; Beth E Snitz; Ching-Wen Lee; Joni Vanderbilt; Judith A Saxton; Chung-Chou H Chang Journal: Aging Ment Health Date: 2010-01 Impact factor: 3.658
Authors: Katheen A Welsh-Bohmer; Truls Ostbye; Linda Sanders; Carl F Pieper; Kathleen M Hayden; JoAnn T Tschanz; Maria C Norton Journal: Clin Neuropsychol Date: 2008-06-10 Impact factor: 3.535
Authors: Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman Journal: Alzheimers Dement Date: 2008-03 Impact factor: 21.566
Authors: David R Roalf; Paul J Moberg; Sharon X Xie; David A Wolk; Stephen T Moelter; Steven E Arnold Journal: Alzheimers Dement Date: 2012-12-21 Impact factor: 21.566
Authors: Ana Luisa Sosa; Emiliano Albanese; Martin Prince; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Juan Llibre de Rodriguez; Aquiles Salas; Fang Yang; Ciro Gaona; At Joteeshwaran; Guillermina Rodriguez; Gabriela Rojas de la Torre; Joseph D Williams; Robert Stewart Journal: BMC Neurol Date: 2009-08-26 Impact factor: 2.474